These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21112394)

  • 1. Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms.
    Su B; Wong C; Hong Y; Chen S
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):101-8. PubMed ID: 21112394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase and breast cancer.
    Brodie A; Sabnis G; Jelovac D
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):97-102. PubMed ID: 17113978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells.
    Sun XZ; Zhou D; Chen S
    J Steroid Biochem Mol Biol; 1997; 63(1-3):29-36. PubMed ID: 9449203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation.
    Sirianni R; Capparelli C; Chimento A; Panza S; Catalano S; Lanzino M; Pezzi V; Andò S
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):100-10. PubMed ID: 22906881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 inhibitor nimesulide analogs are aromatase suppressors in breast cancer cells.
    Su B; Cai X; Hong Y; Chen S
    J Steroid Biochem Mol Biol; 2010 Oct; 122(4):232-8. PubMed ID: 20542113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells.
    Masri S; Liu Z; Phung S; Wang E; Yuan YC; Chen S
    Breast Cancer Res Treat; 2010 Nov; 124(1):89-99. PubMed ID: 20054641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellulose nanocrystals derived from chicory plant: an un-competitive inhibitor of aromatase in breast cancer cells via PI3K/AKT/mTOP signalling pathway.
    Allahyari M; Motavalizadeh-Kakhky AR; Mehrzad J; Zhiani R; Chamani J
    J Biomol Struct Dyn; 2024 Jul; 42(11):5575-5589. PubMed ID: 37340682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis.
    Zhou Y; Zeng C; Li X; Wu PL; Yin L; Yu XL; Zhou YF; Xue Q
    J Mol Med (Berl); 2016 Aug; 94(8):887-97. PubMed ID: 26899323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor.
    Vilquin P; Villedieu M; Grisard E; Ben Larbi S; Ghayad SE; Heudel PE; Bachelot T; Corbo L; Treilleux I; Vendrell JA; Cohen PA
    Int J Cancer; 2013 Oct; 133(7):1589-602. PubMed ID: 23553037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
    Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
    Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol as an anti-aromatase agent in human breast cancer cells.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2006 Jan; 98(1):12-7. PubMed ID: 16413774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of a cyclooxygenase-2 inhibitor nimesulide analog JCC76 in aromatase inhibitors-insensitive breast cancer cells.
    Zhong B; Cai X; Yi X; Zhou A; Chen S; Su B
    J Steroid Biochem Mol Biol; 2011 Aug; 126(1-2):10-8. PubMed ID: 21458568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.
    Masri S; Phung S; Wang X; Wu X; Yuan YC; Wagman L; Chen S
    Cancer Res; 2008 Jun; 68(12):4910-8. PubMed ID: 18559539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
    Pasqualini JR; Chetrite G
    Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
    Ghayad SE; Vendrell JA; Ben Larbi S; Dumontet C; Bieche I; Cohen PA
    Int J Cancer; 2010 Jan; 126(2):545-62. PubMed ID: 19609946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.